drugset / Trial / NCT02880670

Pharmacokinetics and Metabolism Study of Radiolabeled BMS-986142 in Healthy Male Subjects

NCT02880670

Phase 1 Completed 9 enrolled Bristol-Myers Squibb
NaSingle-groupOpen-labelTreatment

Summary

This is an open-label, single-dose, study in healthy males. The primary objective is to assess the pharmacokinetics (PK), metabolism, and routes of elimination of a single oral dose of radiolabeled BMS-986142 in healthy male subjects.

Timeline

Start
2016-08
Primary completion
2016-09
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS-986142 Small molecule Oral